Cancer Treatment Ups CV Risk; Therapy's Next Big Thing; Nude Photos Settlement News, features, and commentary about cancer-related issues Sep 26, 2024
Sickle Cell Disease Drug Pulled From Global Markets Benefits of voxelotor (Oxbryta) no longer outweigh the risks, Pfizer says Sep 26, 2024
Gene Therapy for Hemophilia B Significantly Outperforms Factor IX Prophylaxis Fidanacogene elaparvovec reduces bleeding episodes by 71% after a single infusion Sep 25, 2024
Earlier Info on Financial Stress; Obesity and Second Cancers; Carcinogenic Condoms? News, features, and commentary about cancer-related issues Sep 19, 2024
Chemo-Free Triplet Yields 68% Response Rate in Richter Transformation Regimen tops best historical response rate with chemoimmunotherapy in this setting Sep 16, 2024
Cancer Diagnoses Still Lagging; Cancer and Family Health; New Type of Lung Cancer News, features, and commentary about cancer-related issues Sep 12, 2024
Second Malignancy Risk With CAR T-Cell Therapy on Par With Other Treatments Incidence almost identical to that with standard cancer treatment in randomized trials Sep 11, 2024
Study Supports Lactated Ringer Solution for Fluid Resuscitation in SCD For patients with vaso-occlusive episodes, lactated Ringer was better than normal saline Sep 09, 2024
Off-the-Shelf Drug Matches CAR-T Effects in Refractory Lupus Patient achieves remission with biologic agent currently used for myeloma Sep 04, 2024
The Higher the Disability Burden From Disease, the Higher the Suicide Risk Having a medical condition was tied to increased risk of suicide in a dose-response-like manner Sep 04, 2024
Infections the Main Cause of Nonrelapse Mortality After CAR-T for Blood Cancers Systematic review and meta-analysis finds CAR T-cell-specific toxicities only account for 11.5% Sep 04, 2024
BTK Inhibitor Active in Half of Patients With Richter Transformation Responses to pirtobrutinib observed in patients with previously treated disease Sep 03, 2024
Lung Function Stable in Sickle Cell Patients After Non-Myeloablative Transplant Results from some pulmonary function tests even showed improvement 3 years post-transplant Aug 28, 2024
Mixed Results With Cyclophosphamide in Mismatched Unrelated Stem Cell Transplants Better survival in one registry study, detriment with class I HLA mismatch in another Aug 27, 2024
FDA Could Soon Limit Use of Only Drug for COVID Prevention Pemivibart may have reduced activity against growing variant KP.3.1.1, agency warns Aug 27, 2024
Too Many Kids With Sickle Cell Disease Aren't Getting Appropriate Preventive Care Findings from my recent study shook me to my core Aug 26, 2024
More Support for Early Detection; Cancer in Men Rising; Diet Drives Colon Cancer News, features, and commentary about cancer-related issues Aug 16, 2024
Novel Agent for Chronic GVHD Wins FDA Approval Axatilimab achieved a 75% response rate in patients with previously treated chronic GVHD Aug 14, 2024
No Gestational Diabetes-Cancer Link; Cholesterol and Cancer; Oncologist Saves Umpire News, features, and commentary about cancer-related issues Aug 09, 2024
IL-2 Receptor-Targeted Therapy Approved for Relapsed/Refractory CTCL New iteration of denileukin diftitox led to objective responses in 36% of pretreated patients Aug 08, 2024
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies News, features, and commentary about cancer-related issues Aug 02, 2024
FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma Indicated for newly diagnosed patients who are eligible for stem cell transplant Jul 31, 2024
Ancient DNA May Fuel Cancer; ASCO Appeals to Oncologists; Pesticide Cancer Risk News, features, and commentary about cancer-related issues Jul 26, 2024
These Athletes Weren't Doping. Their Genes Made It Look Like They Did. Advanced sequencing revealed genetic reasons for high hemoglobin, hematocrit levels Jul 24, 2024
'Realistic Chance for Pregnancy' After Stem Cell Transplant, German Study Suggests 77% of pregnancies resulted in live births Jul 19, 2024
Top Cancer Centers; Phase III Win in Prostate Cancer; Screening Recs for Anal Cancer News, features, and commentary about cancer-related issues Jul 19, 2024
Efanesoctocog Alfa Prevented Bleeding in Kids With Severe Hemophilia A No factor VIII inhibitors developed among the 74 boys included in the study Jul 17, 2024
A First in Total Larynx Transplant; 'Sniffing' Out Lung Cancer; Gen X Cancer Toll News, features, and commentary about cancer-related issues Jul 12, 2024
Refractory Multiple Myeloma Responsive to Immunotherapy Plus Low-Dose Radiotherapy A third of patients who had received multiple prior lines of therapy responded, small study shows Jul 10, 2024
Belantamab Mafodotin: The Comeback Drug in Multiple Myeloma Joseph Mikhael, MD, leads a discussion on the DREAMM-7 and DREAMM-8 trials Jul 05, 2024 video
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials News, features, and commentary about cancer-related issues Jun 28, 2024
Young Cervical Cancer, Leukemia Survivors at Greater Risk of Obstetric Complications Population-based study suggests reassurance for most, high-risk strategies for some Jun 27, 2024
Subcutaneous C5 Inhibitor Approved for PNH Longer-acting crovalimab designed for more sustained effect and less treatment burden Jun 24, 2024
EU Adds CAR-T Warning; New Blincyto Indication; Good News in Pancreatic Cancer News, features, and commentary about cancer-related issues Jun 21, 2024
Glofitamab Regimen Improves Survival in DLBCL Granted accelerated approval last year, bispecific antibody passes its confirmatory test Jun 20, 2024
Using MRD Status to Deescalate Multiple Myeloma Therapy Joseph Mikhael, MD, leads a discussion on the findings of the MRD2STOP study Jun 20, 2024 video
Multidrug Regimen Could Change Treatment Landscape for Relapsed/Refractory DLBCL High-rate of durable responses with ViPOR sparks talk of supplanting CAR-T in second line Jun 19, 2024
Novel Anti-CD38 Drug Shows Promise for Immune Thrombocytopenia "Rapid and sustained" efficacy in 95% of pretreated patients in small trial Jun 19, 2024
Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL Undetectable MRD rates of 90% or higher, PFS of 7 years or more Jun 17, 2024
New Standard of Care in High-Risk Acute Promyelocytic Leukemia? All-trans retinoic acid plus arsenic trioxide and idarubicin improved EFS over standard Jun 17, 2024
